Every year, more American men over 50 get told they have fatty
liver and walk out of that office with nothing but a pamphlet…
And the numbers are staggering.
NAFLD-related mortality in U.S. adults 65+ has risen at an
annual rate of
16.5% every year since 1999.
But WHY? Why are more men getting sicker than ever before when
the food on the shelves keeps getting "healthier"?
Follow the money.
The first FDA-approved drug for fatty liver disease Rezdiffra
was approved in March 2024.
The cost?
$39,600 to $50,100 per year.
The catch? It only works for late-stage patients who already
have biopsy-proven fibrosis. Most fatty liver patients don't
qualify. And the side effects include diarrhea, nausea, itching,
dizziness, and abdominal pain.
That's a drug priced at the cost of a new pickup truck that most
doctors can't even prescribe to you that the establishment is
calling
"the breakthrough."
Read that again. $40,000 a year. They give you a coin flip on
the side effects.
Is it any wonder these numbers keep climbing every single year?